Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CX | CRH |
|---|---|---|
| Price | $9.33 | $81.63 |
| Change today | ▼ 1.95% | ▼ 1.41% |
| Market cap | $13.46B | $54.31B |
| Return, 3 months | -22.9% | -22.1% |
| Return, year to date | -18.2% | -33.9% |
| Return, 1 year | +5.9% | -30.9% |
| P/E (TTM) | 29.1 | 14.4 |
| P/B | 1.0 | 2.3 |
| P/E percentile vs own 5y | 77th | 35th |
| Dividend yield | 1.05% | 1.86% |
| Revenue growth (YoY, latest qtr) | +12.2% | +5.6% |
| Net profit growth (YoY) | +12.1% | +13.4% |
| Gross margin | 33.6% | 36.2% |
| Operating margin | 12.5% | 14.1% |
| Net margin | 2.8% | 9.9% |
| Return on equity | 3.7% | 16.4% |
| Analyst target vs. price | +57.0% | +64.9% |
| Analyst buy share | 71% | 100% |
| RSI (14) | 32 | 34 |
| 30-day volatility | 29.8% | 26.2% |
| Max drawdown, 1 year | -29.4% | -35.7% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
